China’s Drug GMP aligns with international standards to a considerable extent, with improvements in recent years. While some disparities remain, China has made efforts to enhance its regulatory framework, manufacturing practices, and quality control. Continued collaboration and stringent assessments contribute to bridging the gap between China’s GMP and global standards.
